Hi Outlander, Scott, Pivalde and others.I jumped in here a few...

Hi Outlander, Scott, Pivalde and others.

I jumped in here a few months ago (after reading about the positive primate results) on the off chance the Ph2 trials show levels of efficacy good enough to move to Ph3.

My question is: If the ATH team have a good idea of how the trials are tracking, why hasn't there been strong buying in the lead up to interim results later this month?

In a video conference not long ago, I watched Dr Stamler discuss what ATH was doing in the Ph2 trials but he was careful not to divulge any "new" information. His body language was "neutral" and voice very monotone. I was hoping to see more levels of excitement but alas, he either has a great poker face or the results at that stage were less than impressive?

Maybe still early as past experiences have shown that volumes rise sharply in the days prior to the announcement.

The cat always gets let out of the bag so I am hoping to see good buying at some point in July, after which I will load up again.

Also wanted to say thanks to Pivalde et all for the inciteful posts.

Fingers crossed for all of us!